Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Annals of Oncology

• Publication date

  2014-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/annonc/mdt490PMID 24306042
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element.

  2012cited by this paper
• Multiparametric Analysis of Cell-Free DNA in Melanoma Patients

  2012cited by this paper
• Validation of tumor‐associated macrophage ferritin light chain as a prognostic biomarker in node‐negative breast cancer tumors: A multicentric 2004 national PHRC study

  2012cited by this paper
• Elevation in Inflammatory Serum Biomarkers Predicts Response to Trastuzumab-Containing Therapy

  2012cited by this paper
• Breast density influences tumor subtypes and tumor aggressiveness.

  2011cited by this paper
• Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin.

  2010cited by this paper
• Ferroportin and iron regulation in breast cancer progression and prognosis.

  2010cited by this paper
• In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2.

  2010cited by this paper
• Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway.

  2010cited by this paper
• Ferritin for the clinician.

  2009cited by this paper
• Involvement of Hepcidin in the Anemia of Multiple Myeloma

  2008cited by this paper
• Applied Logistic Regression: Hosmer/Applied Logistic Regression

  2005cited by this paper
• IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.

  2004cited by this paper
• Bravais-Pearson and Spearman correlation coefficients: meaning, test of hypothesis and confidence interval.

  2002cited by this paper
• Methods of correcting for multiple testing: operating characteristics.

  1997cited by this paper
• Flexible regression models with cubic splines.

  1989cited by this paper
• The meaning and use of the area under a receiver operating characteristic (ROC) curve.

  1982cited by this paper
• Nonparametric Statistical Methods: Hollander/Nonparametric Statistical Methods

  1973cited by this paper

• Assessment of Cancer biomarkers and biochemical parameters across breast Cancer stages: Correlation with age and comorbidities.

  2025cites this paper
• Serum Hepcidin Levels in Breast Cancer Patients: Investigating the Correlation to Tumor Stage—A Cross‐Sectional Study

  2025cites this paper
• Association of Serum Ferritin with Total and Regional Fat Measured by Dual-Energy X-Ray Absorptiometry in a Nationally Representative Survey

  2024cites this paper
• HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling

  2023cites this paper
• Can serum ferritin serve as a biomarker for the prognosis of gynecological malignant tumors? A retrospective cohort study

  2023cites this paper
• Biomarker Reproducibility Challenge: A Review of Non-Nucleotide Biomarker Discovery Protocols from Body Fluids in Breast Cancer Diagnosis

  2023cites this paper
• Plasma Profile of Immune Determinants Predicts Pathological Complete Response in Locally Advanced Breast Cancer Patients: A Pilot Study.

  2022cites this paper
• Assessment of iron status markers in patients with lung cancer

  2022cites this paper
• Tumoral Overexpression of Hepcidin is Associated with Poor Prognosis of Patients with Clear Cell Renal Cell Carcinoma

  2022cites this paper
• Breast cancer in the era of integrating “Omics” approaches

  2022cites this paper
• Iron cycle disruption by heme oxygenase-1 activation leads to a reduced breast cancer cell survival.

  2022cites this paper
• High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma

  2022cites this paper
• Advancements of nature nanocage protein: preparation, identification and multiple applications of ferritins

  2021cites this paper
• A Diagnostic Analysis Workflow to Optimal Multiple Tumor Markers to Predict the Nonmetastatic Breast Cancer from Breast Lumps

  2021cites this paper
• Utility of ferritin and inflammatory biomarkers in the diagnosis of different stages of breast cancer

  2021cites this paper
• Osteosarcoma in Children: Not Only Chemotherapy

  2021cites this paper
• Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression.

  2021cites this paper
• Changes in the Serum Concentrations of Essential Trace Metals in Patients with Benign and Malignant Breast Cancers

  2021cites this paper
• Serum Ferritin, Vitamin D and Pathological Factors in Breast Cancer Patients

  2021cites this paper
• The association between serum ferritin levels and malignant intraductal papillary mucinous neoplasms

  2021cites this paper
• Iron Vulnerability of Cancer Stem Cells

  2021cites this paper
• Growth differentiation factor-15 and lactoferrin immuno-expression in breast cancer: relationship with body iron-status and survival outcome

  2021cites this paper
• A systematic review and meta-analysis on the association of serum and tumor tissue iron and risk of breast cancer

  2020cites this paper
• Pretreatment Serum Ferritin as a Prognostic Indicator in Advanced Cancer Patients Treated With Apatinib: A Retrospective Cohort Study

  2020cites this paper
• Assessment of Some Hematological parameters in Iraqi Women with Different Breast Cancer Stages

  2020cites this paper
• Iron promotes breast cancer cell migration via IL-6/JAK2/STAT3 signaling pathways in a paracrine or autocrine IL-6-rich inflammatory environment.

  2020cites this paper
• Circulating Osteocyte-Related Biomarkers (vitamin D, sclerostin, dickkopf-1), hepcidin, and oxidative stress markers in early breast cancer: their impact in disease progression and outcome.

  2020cites this paper
• Iron: An Essential Element of Cancer Metabolism

  2020cites this paper
• Changes of Morphological Characteristics and Metabolic Profile of Walker-256 Carcinosarcoma under the Impact of Exogenous Lactoferrin

  2020cites this paper
• YTHDF1-enhanced iron metabolism depends on TFRC m6A methylation

  2020cites this paper
• Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer

  2020cites this paper
• Iron as a Central Player and Promising Target in Cancer Progression

  2019cites this paper
• Ferritin : A Complementary Tool to PSA in Diagnosis and Differentiation of Ca Prostrate with BPH

  2019cites this paper
• Prognostic Value of Ferritin-to-Hemoglobin Ratio in Patients with Advanced Non-Small-Cell Lung Cancer

  2019cites this paper
• The Effect of Abnormal Iron Metabolism on Osteoporosis

  2019cites this paper
• The effect of red blood cell transfusion on plasma hepcidin and growth differentiation factor 15 in gastric cancer patients: a prospective study.

  2019cites this paper
• Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma

  2019cites this paper
• Association between proteomic profile and molecular response in chronic myeloid leukemia patients

  2018cites this paper
• The role of iron metabolism in cancer therapy focusing on tumor‐associated macrophages

  2018cites this paper
• Challenges in the Management of Chemotherapy Related Anemia

  2018cites this paper
• Estudio del paciente con hiperferritinemia

  2017cites this paper
• Increased expression of hepcidin and associated upregulation of JAK/STAT3 signaling in human gastric cancer

  2017cites this paper
• The Clinical Value of Hepcidin in Breast Cancer and Its Bone Metastasis

  2017influential citation
• Lipocalin-2 and iron trafficking in the tumor microenvironment.

  2017cites this paper
• Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancer

  2017cites this paper
• Targeting iron metabolism in drug discovery and delivery

  2017cites this paper
• Recent advances on the stimulatory effects of metals in breast cancer.

  2017cites this paper
• Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors

  2017cites this paper
• Iron metabolism as a therapeutic target for drug development and delivery

  2017cites this paper
• Physiology of iron metabolism Systemic iron regulation − the hepcidin − ferroportin

  2017cites this paper
• Hepcidin: a real-time biomarker of iron need.

  2017cites this paper
• Iron Homeostasis in Health and Disease

  2016cites this paper
• Informative gene selection and the direct classification of tumors based on relative simplicity

  2016cites this paper
• Noninvasive strategies for breast cancer early detection.

  2016cites this paper
• Iron, Cancer, and Hypoxia-Inducible Factor Signaling

  2016cites this paper
• Hemoglobina reticulocitaria: un nuevo parámetro del hemograma de gran valor en el diagnóstico y manejo de la eritropoyesis deficiente en hierro

  2015cites this paper
• Hepcidin - A novel biomarker with changing trends

  2015cites this paper
• Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone

  2015cites this paper
• Hormone responsive breast cancer and BRCA1 mutation: mechanism, regulation and iron-mediated effects.

  2014cites this paper
• Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation

  2014cites this paper
• Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals

  2014cites this paper
• Plasma ferritin levels, HFE polymorphisms, and risk of pancreatic cancer among Chinese Han population

  2014cites this paper
• Effect of Obesity-associated Iron dysregulation on Breast Cancer Risk in Postmenopausal Women

  2014cites this paper
• Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells.

  2014cites this paper
• Iron homeostasis and anemia markers in early breast cancer.

  2014cites this paper